WO2001087917A8 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
WO2001087917A8
WO2001087917A8 PCT/US2001/014826 US0114826W WO0187917A8 WO 2001087917 A8 WO2001087917 A8 WO 2001087917A8 US 0114826 W US0114826 W US 0114826W WO 0187917 A8 WO0187917 A8 WO 0187917A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2001/014826
Other languages
English (en)
Other versions
WO2001087917A1 (fr
Inventor
Y Tom Tang
Vinod Asundi
Ping Zhou
Aidong J Xue
Feiyan Ren
Jie Zhang
Jian-Rui Wang
Yonghong Yang
Qing A Zhao
Ryle W Goodrich
Chenghua Liu
Radoje T Drmanac
Tom Wehrman
Rui-Hong Chen
Original Assignee
Hyseq Inc
Y Tom Tang
Vinod Asundi
Ping Zhou
Aidong J Xue
Feiyan Ren
Jie Zhang
Jian-Rui Wang
Yonghong Yang
Qing A Zhao
Ryle W Goodrich
Chenghua Liu
Radoje T Drmanac
Tom Wehrman
Rui-Hong Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyseq Inc, Y Tom Tang, Vinod Asundi, Ping Zhou, Aidong J Xue, Feiyan Ren, Jie Zhang, Jian-Rui Wang, Yonghong Yang, Qing A Zhao, Ryle W Goodrich, Chenghua Liu, Radoje T Drmanac, Tom Wehrman, Rui-Hong Chen filed Critical Hyseq Inc
Priority to AU2001263005A priority Critical patent/AU2001263005A1/en
Priority to EP01937252A priority patent/EP1282635A4/fr
Priority to CA002409164A priority patent/CA2409164A1/fr
Publication of WO2001087917A1 publication Critical patent/WO2001087917A1/fr
Priority to US10/294,433 priority patent/US20070049743A1/en
Publication of WO2001087917A8 publication Critical patent/WO2001087917A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne de nouveaux acides nucléiques, de nouvelles séquences polypeptidiques codées par lesdits acides nucléiques et leurs utilisations.
PCT/US2001/014826 2000-05-18 2001-05-16 Nouveaux acides nucleiques et polypeptides WO2001087917A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2001263005A AU2001263005A1 (en) 2000-05-18 2001-05-16 Novel nucleic acids and polypeptides
EP01937252A EP1282635A4 (fr) 2000-05-18 2001-05-16 Nouveaux acides nucleiques et polypeptides
CA002409164A CA2409164A1 (fr) 2000-05-18 2001-05-16 Nouveaux acides nucleiques et polypeptides
US10/294,433 US20070049743A1 (en) 2000-05-18 2002-11-13 Novel nucleic acids and polypeptides

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US57740800A 2000-05-18 2000-05-18
US09/577,408 2000-05-18
US66729800A 2000-09-22 2000-09-22
US09/667,298 2000-09-22
US69578100A 2000-10-24 2000-10-24
US09/695,781 2000-10-24
US71586900A 2000-11-17 2000-11-17
US09/715,869 2000-11-17
US77533001A 2001-02-01 2001-02-01
US09/775,330 2001-02-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/294,433 Continuation-In-Part US20070049743A1 (en) 2000-05-18 2002-11-13 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
WO2001087917A1 WO2001087917A1 (fr) 2001-11-22
WO2001087917A8 true WO2001087917A8 (fr) 2007-07-19

Family

ID=27541930

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/014826 WO2001087917A1 (fr) 2000-05-18 2001-05-16 Nouveaux acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1282635A4 (fr)
AU (1) AU2001263005A1 (fr)
CA (1) CA2409164A1 (fr)
WO (1) WO2001087917A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001257427A1 (en) * 2000-04-28 2001-11-12 Incyte Genomics, Inc. Rna metabolism proteins
EP1434783A4 (fr) * 2001-03-16 2006-06-07 Lilly Co Eli Proteines de mammiferes lp et reactifs associes
WO2002101075A2 (fr) 2001-06-13 2002-12-19 Millennium Pharmaceuticals, Inc. Identification, evaluation, prevention et traitement du cancer du col de l'uterus : nouveaux genes, nouvelles compositions, nouvelles trousses et nouvelles methodes
US20060068434A1 (en) * 2004-09-21 2006-03-30 Jay Stoerker Methods and compositions for detecting cancer using components of the U2 spliceosomal particle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19811193A1 (de) * 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatatumorgewebe
JP2002522062A (ja) * 1998-08-14 2002-07-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
EP1210419A2 (fr) * 1999-03-22 2002-06-05 Incyte Pharmaceuticals, Inc. Proteines transmembranaires humaines

Also Published As

Publication number Publication date
WO2001087917A1 (fr) 2001-11-22
CA2409164A1 (fr) 2001-11-22
EP1282635A1 (fr) 2003-02-12
AU2001263005A1 (en) 2001-11-26
EP1282635A4 (fr) 2005-05-11
AU2001263005A8 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2001075067A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003023013A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2004009834A3 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
WO2001002571A3 (fr) Nouvel antagoniste du recepteur d'interleukin-1 et ses utilisations
WO2003080795A3 (fr) Nouveaux acides nucléiques et polypeptides sécrétés
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001075068A3 (fr) Proteines secretee et polynucleotides codant pour ces proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10294433

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2409164

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001937252

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001937252

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001937252

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10294433

Country of ref document: US